Cannabis and Ecstasy/MDMA: Empirical Measures of Creativity in Recreational Users
Katy A. Jones, M. Blagrove, A. C. Parrott
Journal of Psychoactive Drugs December 1, 2009 DOI: 10.1080/02791072.2009.10399769 via OpenAlex
Summary
AI-generated from the abstractChronic cannabis users generated more rare-creative responses on a test of creativity than non-drug users, a difference that remained after adjusting for gender. Ecstasy users did not differ from controls on behavioral creativity measures but tended to rate their own answers as more creative, though this trend was borderline. There were no group differences in remote-creative ideas or overall fluency. The study compared 15 abstinent cannabis users, 15 abstinent Ecstasy users, and 15 non-drug-user controls on three creativity measures.
Study at a glance
| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 45 |
| Population | Abstinent cannabis users, abstinent Ecstasy users, and nondrug-user controls |
| Citations | 41 |
| Key finding | Cannabis users had significantly more rare-creative responses than controls, while Ecstasy users showed no behavioral differences but a borderline trend toward higher self-rated creativity. |
Abstract
This study investigated the associations between chronic cannabis and Ecstasy/MDMA use and one objective and two subjective measure of creativity. Fifteen abstinent Ecstasy users, 15 abstinent cannabis users, and 15 nondrug-user controls, completed three measures of creativity: the Consequences behavioral test of creativity, self-assessed performance on the Consequences test, and Gough's Trait Self-Report Creative Adjective Checklist. The Consequences test involved five scenarios where possible consequences had to be devised; scoring was conducted by the standard blind rating (by two independent judges) for "remoteness" and "rarity," and by a frequency and rarity of responses method. Cannabis users had significantly more "rare-creative" responses than controls (Tukey, p < 0.05); this effect remained significant with gender as a covariate. There were no significant differences between the groups on the number of standard scoring "remote-creative" ideas or for fluency of responses. On self-rated creativity, there was a significant ANOVA group difference (p < 0.05), with Ecstasy users tending to rate their answers as more creative than controls (Tukey comparison; p = 0.058, two-tailed). Ecstasy users did not differ from controls on the behavioral measures of creativity, although there was a borderline trend for self-assessment of greater creativity. Cannabis users produced significantly more "rare-creative" responses, but did not rate themselves as more creative.